Abe Tsuyoshi, Kakemura Tadayoshi, Fujinuma Sumio, Maetani Iruru
Division of Gastroenterology, Department of Internal Medicine, Toho University Ohashi Medical Center, 2-17-6 Ohashi Meguro-ku, Tokyo 153-8515, Japan.
World J Gastroenterol. 2008 Jul 7;14(25):4054-8. doi: 10.3748/wjg.14.4054.
To assess the results of endoscopic mucosal resection with a ligation device (EMR-L) combined with three dimensional endoscopic ultrasonography (3D-EUS) using an ultrasonic probe for rectal carcinoids. In addition, diagnosis of the depth and size of lesions by EUS was evaluated.
Between January 2003 and March 2007, 20 patients underwent EMR-L with 3D-EUS using an ultrasonic probe (group A). 3D-EUS was combined with EMR-L at the time of injection of sterile physiological saline into the submucosal layer. For comparison, 14 rectal carcinoids that had been treated by EMR-L without 3D-EUS between April 1998 and December 2002 were evaluated as historical controls (group B). EUS was conducted for all of the patients before treatment to evaluate tumor diameter and depth of invasion. The percentage of complete resection and the vertical resection margin were compared between the two groups.
The depth of invasion upon histopathological examination was in complete agreement with the pre-operative findings by EUS. The tumor diameter determined by EUS approximated that found in the tissue samples. There were no significant differences in the gender, tumor sites or tumor diameters between the two groups. The rate of complete resection for groups A and B was 100% and 71%, respectively (P<0.05). The vertical resection margin of group A was longer than that of group B.
EMR-L is effective as an endoscopic treatment for rectal carcinoids. In combination with 3D-EUS, safe and complete resection is further assured.
评估使用结扎装置的内镜黏膜切除术(EMR-L)联合三维内镜超声检查(3D-EUS)及超声探头对直肠类癌的治疗效果。此外,还对通过EUS诊断病变深度和大小的情况进行了评估。
2003年1月至2007年3月期间,20例患者接受了使用超声探头的EMR-L联合3D-EUS治疗(A组)。在向黏膜下层注射无菌生理盐水时,将3D-EUS与EMR-L相结合。为作比较,将1998年4月至2002年12月期间14例接受过未联合3D-EUS的EMR-L治疗的直肠类癌患者作为历史对照(B组)。对所有患者在治疗前进行EUS检查,以评估肿瘤直径和浸润深度。比较两组的完全切除率和垂直切缘情况。
组织病理学检查的浸润深度与EUS术前检查结果完全一致。EUS测定的肿瘤直径与组织样本中的肿瘤直径相近。两组在性别、肿瘤部位或肿瘤直径方面无显著差异。A组和B组的完全切除率分别为100%和71%(P<0.05)。A组的垂直切缘比B组长。
EMR-L作为直肠类癌的内镜治疗方法是有效的。联合3D-EUS可进一步确保安全、完整切除。